Protein engineering company Codexis has accused competitor Codex DNA of trademark infringement through the use of a “virtually identical” mark.
Canada’s Department of Agriculture and Agri-Food has accused a Washington-based nursery, a fruit seller, and a fruit grower of infringing a plant patent covering the Staccato type of cherry tree.
Sanofi is facing criticism after CEO Paul Hudson said the US was likely to have priority access on any COVID-19 vaccine produced by the French pharmaceutical company.
IP firm HGF has appointed two patent attorneys to partner, increasing the partner group to 63 partners.
The University of Oxford has partnered with UK pharmaceutical company AstraZeneca to develop and manufacture the university’s trial COVID-19 vaccine.
A total of 79 vaccines and 155 drugs are currently being developed across the globe to combat COVID-19, according to statistics from the Austrian Institute for Health Technology Assessment.
Bulgaria-based Huvepharma has accused chemicals company BASF and Dutch life sciences Koninklijke DSM, known as Royal DSM, of infringing its feed additive.
Sanofi and GlaxoSmithKline are pooling resources to create a vaccine for COVID-19, in what they call an “unprecedented” collaboration between the two pharma companies.
Millipore Sigma, the US life sciences business of Merck KGaA, has secured a patent for its CRISPR-chrom technology, bringing its total number of CRISPR-related patents to 23.
The Biotechnology Innovation Organization has converted its 2020 international convention into an entirely online experience, BIO Digital.